These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 5436029)

  • 1. Chromosome studies on patients (in vivo) and cells (in vitro) treated with lysergic acid diethylamide.
    Corey MJ; Andrews JC; McLeod MJ; MacLean JR; Wilby WE
    N Engl J Med; 1970 Apr; 282(17):939-43. PubMed ID: 5436029
    [No Abstract]   [Full Text] [Related]  

  • 2. Similarities and differences between mescaline, lysergic acid diethylamide-25 (LSD) and d-amphetamine on various components of fixed interval responding in the rat.
    Tilson HA; Sparber SB
    J Pharmacol Exp Ther; 1973 Feb; 184(2):376-84. PubMed ID: 4688175
    [No Abstract]   [Full Text] [Related]  

  • 3. Chromosomal damage in human leukocytes induced by lysergic acid diethylamide.
    Cohen MM; Marinello MJ; Back N
    Science; 1967 Mar; 155(3768):1417-9. PubMed ID: 6018505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of mescaline and lysergic acid diethylamide on flicker discrimination in the rat.
    Schechter MD; Winter JC
    J Pharmacol Exp Ther; 1971 May; 177(2):461-7. PubMed ID: 5568801
    [No Abstract]   [Full Text] [Related]  

  • 5. Chromosomal effect in vivo of exposure to lysergic acid diethylamide.
    Sparkes RS; Melnyk J; Bozzetti LP
    Science; 1968 Jun; 160(3834):1343-5. PubMed ID: 5651893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo and in vitro chromosomal damage induced by LSD-25.
    Cohen MM; Hirschhorn K; Frosch WA
    N Engl J Med; 1967 Nov; 277(20):1043-9. PubMed ID: 4862522
    [No Abstract]   [Full Text] [Related]  

  • 7. Psychopharmacological studies of lysergic acid diethylamide (LSD-25) intoxication; effects of premedication with BOL-128 (2-bromo-d-lysergic acid diethylamide), mescaline, atropine, amobarbital, and chlorpromazine.
    CLARK LD; BLISS EL
    AMA Arch Neurol Psychiatry; 1957 Dec; 78(6):653-5. PubMed ID: 13478222
    [No Abstract]   [Full Text] [Related]  

  • 8. Patterns of tolerance to lysergic acid diethylamide and mescaline in rats.
    FREEDMAN DX; AGHAJANIAN GK; ORNITZ EM
    Science; 1958 May; 127(3307):1173-4. PubMed ID: 13555858
    [No Abstract]   [Full Text] [Related]  

  • 9. LSD-25 and genetic damage.
    Kato T; Jarvik LF
    Dis Nerv Syst; 1969 Jan; 30(1):42-6. PubMed ID: 5775758
    [No Abstract]   [Full Text] [Related]  

  • 10. [The cytogenetic and teratogenic effects of LSD-25 (review of the literature)].
    Finogenova SA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1970 May; 70(5):770-6. PubMed ID: 4916174
    [No Abstract]   [Full Text] [Related]  

  • 11. PSYCHODYNAMIC and therapeutic aspects of mescaline and lysergic acid diethylamide: round table.
    J Nerv Ment Dis; 1957; 125(3):423-4. PubMed ID: 13481746
    [No Abstract]   [Full Text] [Related]  

  • 12. Antidiuresis in man following lysergic acid diethylamide and mescaline.
    Hollister LE; Kanter SL; Dronkert A
    Behav Neuropsychiatry; 1970; 2(3):50-4. PubMed ID: 4913153
    [No Abstract]   [Full Text] [Related]  

  • 13. Leukocytes of humans exposed to lysergic acid diethylamide: lack of chromosomal damage.
    Loughman WD; Sargent TW; Israelstam DM
    Science; 1967 Oct; 158(3800):508-10. PubMed ID: 6048108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Influence of mescaline and of lysergic acid diethylamide (LSD-25) on the development of primary and secondary conditioned avoidance reflexes in rats].
    MAFFII G
    Farmaco Sci; 1959 Jul; 14():503-15. PubMed ID: 13853753
    [No Abstract]   [Full Text] [Related]  

  • 15. Tolerance to a behavioral effect of lysergic acid diethylamide and cross-tolerance to mescaline in the rat: absence of a metabolic component.
    Winter JC
    J Pharmacol Exp Ther; 1971 Sep; 178(3):625-30. PubMed ID: 5571911
    [No Abstract]   [Full Text] [Related]  

  • 16. Mescaline and lysergic acid diethylamide: therapeutic implications of the drug-induced state.
    Denber HC
    Dis Nerv Syst; 1969 Feb; 30(2):Suppl:23-7. PubMed ID: 5775311
    [No Abstract]   [Full Text] [Related]  

  • 17. Prolonged survival of the isolated retina induced by drugs; strychnine, mescaline, d-lysergic acid diethylamide (LSD), and atropine.
    APTER JT
    AMA Arch Ophthalmol; 1958 May; 59(5):722-30. PubMed ID: 13519998
    [No Abstract]   [Full Text] [Related]  

  • 18. [Change in complex forms of conditioned reflexes caused by the application of lysergic acid diethylamide (LSD) and mescaline to the cortical ends of the auditory and visual analyzers].
    Alekseeva LA
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1969; 19(2):279-85. PubMed ID: 5404353
    [No Abstract]   [Full Text] [Related]  

  • 19. Identification of short time intervals under LSD25 and mescaline.
    Mitrani L; Shekerdjiiski S; Gourevitch A; Yanev S
    Act Nerv Super (Praha); 1977 May; 19(2):103-4. PubMed ID: 888639
    [No Abstract]   [Full Text] [Related]  

  • 20. Pre- and post-LSD chromosomal aberrations: a comparative study.
    Tjio JH; Pahnke WN; Kurland AA
    Adv Biochem Psychopharmacol; 1969; 1():191-204. PubMed ID: 5407192
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.